Repetitive High-Dose Topotecan, Carboplatin, and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study

This publication has 25 references indexed in Scilit:

• Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer
  Bone Marrow Transplantation, 1999
• Back to the Future: Multiagent Chemotherapy in Ovarian Cancer Revisited
  Journal of Clinical Oncology, 1999
• Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer
  Cancer, 1999
• Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.
  Journal of Clinical Oncology, 1998
• Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.
  Journal of Clinical Oncology, 1998
• Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma
  Annals of Oncology, 1997
• Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
  Journal of Clinical Oncology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
  Journal of Clinical Oncology, 1994
• Rapid Delivery of Multiple High-Dose Chemotherapy Courses With Granulocyte Colony-Stimulating Factor and Peripheral Blood-Derived Hematopoietic Progenitor Cells
  JNCI Journal of the National Cancer Institute, 1992